Irina N. Danusevich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irina N. Danusevich has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Larisa Victorovna Suturina
Scientific centre for Family Health and Human Reproduction Problems
25 shared publications - Lyudmila M. Lazareva
Scientific centre for Family Health and Human Reproduction Problems
24 shared publications - Alina Valerievna Atalyan
Scientific centre for Family Health and Human Reproduction Problems
20 shared publications - Iana Gennad'Evna Nadeliaeva
Scientific centre for Family Health and Human Reproduction Problems
20 shared publications - Leonid Fedorovich Sholokhov
Scientific centre for Family Health and Human Reproduction Problems
14 shared publications - Liliia V. Belenkaia
Scientific centre for Family Health and Human Reproduction Problems
10 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (10) , 579-583
Indirect indices of insulin resistance in different ethnicities women with complete and incomplete symptom complex of metabolic syndrome
Аim. To analyze of insulin resistance indirect indices in women of different ethnicities with a complete and incomplete symptom complex of metabolic syndrome (MS). Materials and methods. A total of 1,162 women aged 18-44 years were examined during a preventive examination. They were divided according to ethnicity into: control groups – healthy women (Caucasians; n=68; Asians; n=24), groups with an incomplete symptom complex of MS (Caucasians; n=540; Asians; n=237), and groups with a complete symptom complex of MS (Caucasians; n=209; Asians; n=84). Results. Caucasian women with an incomplete symptom complex of MS have higher indices of CVAI, LAP, BFP, WTI, VAI, TYG; with a complete symptom complex – elevated indices of CVAI, LAP, WC, BFP, BAI, WTI, VAI, TYG, TG/HDL (compared to the control). In Asian women with an incomplete symptom complex of MS, we noted statistically significantly higher indices of CVAI, LAP, WC/height, BFP, TYG; in the group with a complete symptom complex of MS – high levels of CVAI, LAP, WC/height, BFP, BAI, WTI, VAI, TYG, TG/HDL (relative to the control). Ethnic differences were expressed in a higher WC/height ratio (incomplete symptom complex groups) and a lower BAI (complete symptom complex group) in Asian women relative to Caucasians. Conclusion. Understanding the ethnic characteristics of insulin resistance manifestation contributes to the development of personalized prevention and correction strategies.
- 27 August 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (10) , 579-583
Open AccessIndirect indices of insulin resistance in different ethnicities women with complete and incomplete symptom complex of metabolic syndrome
Аim. To analyze of insulin resistance indirect indices in women of different ethnicities with a complete and incomplete symptom complex of metabolic syndrome (MS). Materials and methods. A total of 1,162 women aged 18-44 years were examined during a preventive examination. They were divided according to ethnicity into: control groups – healthy women (Caucasians; n=68; Asians; n=24), groups with an incomplete symptom complex of MS (Caucasians; n=540; Asians; n=237), and groups with a complete symptom complex of MS (Caucasians; n=209; Asians; n=84). Results. Caucasian women with an incomplete symptom complex of MS have higher indices of CVAI, LAP, BFP, WTI, VAI, TYG; with a complete symptom complex – elevated indices of CVAI, LAP, WC, BFP, BAI, WTI, VAI, TYG, TG/HDL (compared to the control). In Asian women with an incomplete symptom complex of MS, we noted statistically significantly higher indices of CVAI, LAP, WC/height, BFP, TYG; in the group with a complete symptom complex of MS – high levels of CVAI, LAP, WC/height, BFP, BAI, WTI, VAI, TYG, TG/HDL (relative to the control). Ethnic differences were expressed in a higher WC/height ratio (incomplete symptom complex groups) and a lower BAI (complete symptom complex group) in Asian women relative to Caucasians. Conclusion. Understanding the ethnic characteristics of insulin resistance manifestation contributes to the development of personalized prevention and correction strategies.
- 25 June 2026
- Published by ECO-Vector LLC (Publications) in Journal of obstetrics and women's diseases
- Vol. 75 (3) , 16-27
Ethnically determined changes in hormonal regulation in women of reproductive age with uterine fibroids
BACKGROUND: The established differences in the incidence of uterine fibroids between ethnic groups require a study of their endocrine causes. A comparative analysis of the hormonal profile in women of European and Mongoloid ethnic groups will reveal specific patterns that may account for the observed epidemiological heterogeneity and identify individual pathogenetic mechanisms of the disease. AIM: The aim of this study was to determine ethno-specific features of hormonal regulation in reproductive-aged women with uterine fibroids based on a comparative analysis of pituitary and steroid hormone levels between European and Mongoloid ethnic groups. METHODS: This study is based on data derived from a multicenter cross-sectional epidemiological study. The study sample included 1,041 women (aged 18–44 years) of European (n = 725) and Mongoloid (n = 316) ethnic groups. The hormonal profile was analyzed using liquid chromatography with tandem mass spectrometry (testosterone), enzyme-linked immunosorbent assay (follicle-stimulating and luteinizing hormones, thyroid-stimulating hormone, prolactin, progesterone, 17-hydroprogesterone, estradiol, estrone, estrone metabolites, sex hormone-binding globulin), and chemiluminescent immunoassay (dehydroepiandrosterone sulfate). The free androgen index was calculated. Statistical analysis was performed using R. RESULTS: Uterine fibroids were more prevalent in the Mongoloid ethnic group (18.35%) compared to the European ethnic group (12.28%; p = 0.01). Comparative analysis of the hormonal profile, without stratification by ethnicity, revealed differences between patients with uterine fibroids and the comparison group only for the levels of prolactin (p = 0.01), testosterone (p = 0.006), and dehydroepiandrosterone sulfate (p = 0.002) in the luteal phase, although the median values remained within the reference range. In the European ethnic group, patients with uterine fibroids showed elevations in luteal phase prolactin (p = 0.014) and testosterone levels (p = 0.024). In the Mongoloid ethnic group, patients with uterine fibroids demonstrated a decrease in dehydroepiandrosterone sulfate levels (p = 0.002) during the luteal phase. Among patients of the Mongoloid ethnic group, prolactin levels were higher compared to those of the European ethnic group. This finding was consistent in both the uterine fibroids group (p = 0.003) and the comparison group (p 0.001). CONCLUSION: In women of the Mongoloid ethnic group with uterine fibroids, a trend toward a combined alteration in prolactin and dehydroepiandrosterone sulfate levels in the luteal phase is observed, which is less pronounced in the European ethnic group. The identified ethnic variability in prolactin and androgen levels in uterine fibroids highlights the importance of an in-depth study of the ethnic aspects of disease pathogenesis.
- 25 June 2026
- Published by ECO-Vector LLC (Publications) in Journal of obstetrics and women's diseases
- Vol. 75 (3) , 16-27
Ethnically determined changes in hormonal regulation in women of reproductive age with uterine fibroids
BACKGROUND: The established differences in the incidence of uterine fibroids between ethnic groups require a study of their endocrine causes. A comparative analysis of the hormonal profile in women of European and Mongoloid ethnic groups will reveal specific patterns that may account for the observed epidemiological heterogeneity and identify individual pathogenetic mechanisms of the disease. AIM: The aim of this study was to determine ethno-specific features of hormonal regulation in reproductive-aged women with uterine fibroids based on a comparative analysis of pituitary and steroid hormone levels between European and Mongoloid ethnic groups. METHODS: This study is based on data derived from a multicenter cross-sectional epidemiological study. The study sample included 1,041 women (aged 18–44 years) of European (n = 725) and Mongoloid (n = 316) ethnic groups. The hormonal profile was analyzed using liquid chromatography with tandem mass spectrometry (testosterone), enzyme-linked immunosorbent assay (follicle-stimulating and luteinizing hormones, thyroid-stimulating hormone, prolactin, progesterone, 17-hydroprogesterone, estradiol, estrone, estrone metabolites, sex hormone-binding globulin), and chemiluminescent immunoassay (dehydroepiandrosterone sulfate). The free androgen index was calculated. Statistical analysis was performed using R. RESULTS: Uterine fibroids were more prevalent in the Mongoloid ethnic group (18.35%) compared to the European ethnic group (12.28%; p = 0.01). Comparative analysis of the hormonal profile, without stratification by ethnicity, revealed differences between patients with uterine fibroids and the comparison group only for the levels of prolactin (p = 0.01), testosterone (p = 0.006), and dehydroepiandrosterone sulfate (p = 0.002) in the luteal phase, although the median values remained within the reference range. In the European ethnic group, patients with uterine fibroids showed elevations in luteal phase prolactin (p = 0.014) and testosterone levels (p = 0.024). In the Mongoloid ethnic group, patients with uterine fibroids demonstrated a decrease in dehydroepiandrosterone sulfate levels (p = 0.002) during the luteal phase. Among patients of the Mongoloid ethnic group, prolactin levels were higher compared to those of the European ethnic group. This finding was consistent in both the uterine fibroids group (p = 0.003) and the comparison group (p 0.001). CONCLUSION: In women of the Mongoloid ethnic group with uterine fibroids, a trend toward a combined alteration in prolactin and dehydroepiandrosterone sulfate levels in the luteal phase is observed, which is less pronounced in the European ethnic group. The identified ethnic variability in prolactin and androgen levels in uterine fibroids highlights the importance of an in-depth study of the ethnic aspects of disease pathogenesis.
- Open Access
- 26 March 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (1) , 34-49
Prevalence of menstrual disorders in adolescent girls with taking into account gynecologic age: a cross-sectional study
Menstrual disorders (MD) in adolescents are the predictor of reproductive problems in older age; nevertheless, the data on the prevalence of MD in adolescent girls are controversial. The aim . To estimate the prevalence of menstrual disorders in the urban subpopulation of 14-17-year-old adolescent girls taking into account their gynecological age. Methods . A cross-sectional study (2020-2023) was conducted with the participation of 417 adolescent girls - students of 1-2 years of pedagogical college, students of 9-11 grades of Lyceum No. 3, and School No. 14 in Irkutsk. The study used a questionnaire survey method and general clinical examination. The incidence of menstrual irregularity was assessed. Statistical analysis methods included descriptive statistics and statistical hypothesis testing. Results . Four hundred seventeen adolescent girls aged 16.18 ± 0.7 years were examined. Menstrual dysfunction (MD) was detected in 56.35 % (235/417) of girls, and more than one type of dysfunction was observed. The most common disorder was oligomenorrhea, which occurred both in isolation and in combination with other dysfunctions, and was present in 31.17 % (130/417) of the girls; 23.3 % of the girls (97/417) suffered from abnormal uterine bleeding (AUB), and 20.62 % (86/417) suffered from dysmenorrhea. In the structure of menstrual function disorders, isolated oligomenorrhea was detected in 29.79 % (70/235), oligomenorrhea in combination with AUB was detected in 15.74 % (37/235), AUB alone in 15.32 % (36/235), amenorrhea in 2.55 % (6/235) of adolescents, isolated dysmenorrhea occurred in 20.85 % of cases (49/235), and in combination with other types of MD - in 15.74 % (37/235) of the surveyed. Conclusion . The results of the study indicate a significant frequency of menstrual disorders in a non-selective (non-hospital) sample of 14-17-year-old female adolescent students. The data obtained dictate the need for active detection and correction of menstrual cycle disorders, a prognostically significant marker of the state of the reproductive system in adolescent girls.
- 26 March 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (1) , 34-49
Open AccessPrevalence of menstrual disorders in adolescent girls with taking into account gynecologic age: a cross-sectional study
Menstrual disorders (MD) in adolescents are the predictor of reproductive problems in older age; nevertheless, the data on the prevalence of MD in adolescent girls are controversial. The aim . To estimate the prevalence of menstrual disorders in the urban subpopulation of 14-17-year-old adolescent girls taking into account their gynecological age. Methods . A cross-sectional study (2020-2023) was conducted with the participation of 417 adolescent girls - students of 1-2 years of pedagogical college, students of 9-11 grades of Lyceum No. 3, and School No. 14 in Irkutsk. The study used a questionnaire survey method and general clinical examination. The incidence of menstrual irregularity was assessed. Statistical analysis methods included descriptive statistics and statistical hypothesis testing. Results . Four hundred seventeen adolescent girls aged 16.18 ± 0.7 years were examined. Menstrual dysfunction (MD) was detected in 56.35 % (235/417) of girls, and more than one type of dysfunction was observed. The most common disorder was oligomenorrhea, which occurred both in isolation and in combination with other dysfunctions, and was present in 31.17 % (130/417) of the girls; 23.3 % of the girls (97/417) suffered from abnormal uterine bleeding (AUB), and 20.62 % (86/417) suffered from dysmenorrhea. In the structure of menstrual function disorders, isolated oligomenorrhea was detected in 29.79 % (70/235), oligomenorrhea in combination with AUB was detected in 15.74 % (37/235), AUB alone in 15.32 % (36/235), amenorrhea in 2.55 % (6/235) of adolescents, isolated dysmenorrhea occurred in 20.85 % of cases (49/235), and in combination with other types of MD - in 15.74 % (37/235) of the surveyed. Conclusion . The results of the study indicate a significant frequency of menstrual disorders in a non-selective (non-hospital) sample of 14-17-year-old female adolescent students. The data obtained dictate the need for active detection and correction of menstrual cycle disorders, a prognostically significant marker of the state of the reproductive system in adolescent girls.
- Open Access
- 25 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 2974
Gut Microorganisms as Markers of Hyperandrogenemia in Premenopausal Women with Polycystic Ovary Syndrome
Previously, the role of decreased biodiversity of gut microbiota in polycystic ovary syndrome (PCOS) was demonstrated, but the objective criteria for assessing the representation of microorganisms associated with hyperandrogenemia (HA) were limited. A total of 175 premenopausal women (26 women with PCOS and HA and 149 women without HA, including 19 healthy controls) were recruited during the Eastern Siberia PCOS Epidemiology and Phenotype (ESPEP) Study (2016–2019). Methods included a questionnaire survey, clinical examination, pelvic U/S, blood and feces sampling. Gut microbiome was analyzed by high-throughput sequencing of the V1–V3 of the variable regions of the 16S rRNA gene (Illumina MiSeq, San Diego, CA, USA). Amplicon libraries of 16S rDNA were processed using the QIIME2 bioinformatics pipeline. All data were analyzed using R 3.6.3. The gut microbiocenosis in women with HA was characterized by a higher representation of Lactobacillus and a lower prevalence of the Clostridia class. For Faecalibacterium, Christensenellaceae_R-7_group, and [Eubacterium] eligens group the cut-off values of their relative presence, associated with HA, were estimated as: ≤0.043%, ≤0.039%, and ≤0.02%, respectively. Conclusions: Women with PCOS-associated HA demonstrate a lower prevalence, predominantly, of Clostridia class gut microorganisms, compared with those without any forms of HA. The study presents the quantitative criteria for assessing the representation of gut microorganisms, negatively associated with hyperandrogenic phenotypes of PCOS. The threshold values proposed may be useful to justify the administration of probiotics in PCOS patients with HA.
- 25 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 2974
Open AccessGut Microorganisms as Markers of Hyperandrogenemia in Premenopausal Women with Polycystic Ovary Syndrome
Previously, the role of decreased biodiversity of gut microbiota in polycystic ovary syndrome (PCOS) was demonstrated, but the objective criteria for assessing the representation of microorganisms associated with hyperandrogenemia (HA) were limited. A total of 175 premenopausal women (26 women with PCOS and HA and 149 women without HA, including 19 healthy controls) were recruited during the Eastern Siberia PCOS Epidemiology and Phenotype (ESPEP) Study (2016–2019). Methods included a questionnaire survey, clinical examination, pelvic U/S, blood and feces sampling. Gut microbiome was analyzed by high-throughput sequencing of the V1–V3 of the variable regions of the 16S rRNA gene (Illumina MiSeq, San Diego, CA, USA). Amplicon libraries of 16S rDNA were processed using the QIIME2 bioinformatics pipeline. All data were analyzed using R 3.6.3. The gut microbiocenosis in women with HA was characterized by a higher representation of Lactobacillus and a lower prevalence of the Clostridia class. For Faecalibacterium, Christensenellaceae_R-7_group, and [Eubacterium] eligens group the cut-off values of their relative presence, associated with HA, were estimated as: ≤0.043%, ≤0.039%, and ≤0.02%, respectively. Conclusions: Women with PCOS-associated HA demonstrate a lower prevalence, predominantly, of Clostridia class gut microorganisms, compared with those without any forms of HA. The study presents the quantitative criteria for assessing the representation of gut microorganisms, negatively associated with hyperandrogenic phenotypes of PCOS. The threshold values proposed may be useful to justify the administration of probiotics in PCOS patients with HA.
- Open Access
- 26 February 2026
- Published by MDPI AG in Preprints.org
Microbiome-Associated Markers of Hyperandrogenemia in Premenopausal Women with Polycystic Ovary Syndrome
Previously, the role of decreased biodiversity of gut microbiota in polycystic ovary syndrome (PCOS) was demonstrated, but the objective criteria for assessing the representation of microorganisms, associated with are limited. A total number of 175 premenopausal women (26 women with PCOS and HA and 149 women without HA, including 19 healthy controls) were recruited during the Eastern Siberia PCOS Epidemiology and Phenotype (ESPEP) Study (2016-2019). Methods included a questionnaire survey, clinical examination, pelvic U/S, blood and feces sampling. Gut microbiome was analized by high-throughput sequencing of the V1–V3 of the variable regions of the 16S rRNA gene (Illumina MiSeq, USA). Amplicon libraries of 16S rDNA were processed using the QIIME2 bioinformatics pipeline. All data were analyzed using R 3.6.3. The gut microbiocenosis in women with HA was characterized by higher representation, predominantly, of Lactobacillus and a less prevalence of Clostridia class. For Faecalibacterium, Christensenellaceae_R-7_group, and [Eubacterium] eligens group the cut-offs values of their relative presence, associated with HA, were estimated as: ≤0.043%, ≤0.039%, and ≤0.02%, respectively. Conclusions: HA in PCOS is associated with a less prevalence of Clostridia class gut microorganisms, predominantly. The threshold values proposed may be useful to justify the administration of probiotics.
- 26 February 2026
- Published by MDPI AG in Preprints.org
Open AccessMicrobiome-Associated Markers of Hyperandrogenemia in Premenopausal Women with Polycystic Ovary Syndrome
Previously, the role of decreased biodiversity of gut microbiota in polycystic ovary syndrome (PCOS) was demonstrated, but the objective criteria for assessing the representation of microorganisms, associated with are limited. A total number of 175 premenopausal women (26 women with PCOS and HA and 149 women without HA, including 19 healthy controls) were recruited during the Eastern Siberia PCOS Epidemiology and Phenotype (ESPEP) Study (2016-2019). Methods included a questionnaire survey, clinical examination, pelvic U/S, blood and feces sampling. Gut microbiome was analized by high-throughput sequencing of the V1–V3 of the variable regions of the 16S rRNA gene (Illumina MiSeq, USA). Amplicon libraries of 16S rDNA were processed using the QIIME2 bioinformatics pipeline. All data were analyzed using R 3.6.3. The gut microbiocenosis in women with HA was characterized by higher representation, predominantly, of Lactobacillus and a less prevalence of Clostridia class. For Faecalibacterium, Christensenellaceae_R-7_group, and [Eubacterium] eligens group the cut-offs values of their relative presence, associated with HA, were estimated as: ≤0.043%, ≤0.039%, and ≤0.02%, respectively. Conclusions: HA in PCOS is associated with a less prevalence of Clostridia class gut microorganisms, predominantly. The threshold values proposed may be useful to justify the administration of probiotics.
- Open Access
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
Metabolic Syndrome in a Multiethnic Population of Peri- and Postmenopausal Women
Aim. To determine ethnic-specific differences in the prevalence and phenotype of metabolic syndrome (MS) during the peri- and postmenopause period in women of Caucasian, Asian, and mixed-ethnicity women. Design. Multicenter, cross-sectional study. Materials and methods. The study was conducted in the city of Irkutsk and the settlement of Bokhan (Irkutsk region), as well as in the city of Ulan-Ude (Republic of Buryatia) from 2016 to 2019. The study included 1 250 peri/postmenopausal women (mean age 51.53 ± 7.95 years) receiving annual routine health check-ups. The participants were divided into three groups: 790 (63.20%) Caucasian, 387 (30.96%) Asian, and 73 (5.84%) women of mixed-ethnicity women. Evaluations included a questionnaire, general clinical examination (with waist circumference and blood pressure measurements), gynecological examinations, and assessment of biochemical markers required for MS verification: high-density lipoprotein cholesterol (HDL-C), triacylglycerides and fasting glucose levels. Results. The overall prevalence of MS in the study cohort was 41.8% (523/1 250). The syndrome was significantly more common among Caucasian women (46.2%, 365/790) and those of mixed ethnicity (42.5%, 31/73), compared with the Asian cohort (32.8%, 127/387); p < 0.001. The most common MS components in all groups were increased waist circumference, arterial hypertension, and low HDL-C levels. Regarding the phenotypic structure of MS, a combination of three criteria was identified in the majority of patients — 70.6% (369/523). The presence of all five components (complete phenotype; 8.2%, 30/365), as well as a higher prevalence of fasting hyperglycaemia (53.7%, 196/365 vs. 38.6%, 49/127 in Asian women; p = 0.003) was observed predominantly in the Caucasian group. Conclusion. Significant ethnic differences in the prevalence and phenotypic structure of MS during the peri- and postmenopause were established, with the highest overall detection rate of the syndrome, its complete phenotype, and hyperglycaemia observed in Caucasian women. These findings support the need for developing ethnic-specific approaches to screening for metabolic disorders and preventing cardiometabolic diseases. Keywords: metabolic syndrome, perimenopause, postmenopause, ethnicity
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
Open AccessMetabolic Syndrome in a Multiethnic Population of Peri- and Postmenopausal Women
Aim. To determine ethnic-specific differences in the prevalence and phenotype of metabolic syndrome (MS) during the peri- and postmenopause period in women of Caucasian, Asian, and mixed-ethnicity women. Design. Multicenter, cross-sectional study. Materials and methods. The study was conducted in the city of Irkutsk and the settlement of Bokhan (Irkutsk region), as well as in the city of Ulan-Ude (Republic of Buryatia) from 2016 to 2019. The study included 1 250 peri/postmenopausal women (mean age 51.53 ± 7.95 years) receiving annual routine health check-ups. The participants were divided into three groups: 790 (63.20%) Caucasian, 387 (30.96%) Asian, and 73 (5.84%) women of mixed-ethnicity women. Evaluations included a questionnaire, general clinical examination (with waist circumference and blood pressure measurements), gynecological examinations, and assessment of biochemical markers required for MS verification: high-density lipoprotein cholesterol (HDL-C), triacylglycerides and fasting glucose levels. Results. The overall prevalence of MS in the study cohort was 41.8% (523/1 250). The syndrome was significantly more common among Caucasian women (46.2%, 365/790) and those of mixed ethnicity (42.5%, 31/73), compared with the Asian cohort (32.8%, 127/387); p < 0.001. The most common MS components in all groups were increased waist circumference, arterial hypertension, and low HDL-C levels. Regarding the phenotypic structure of MS, a combination of three criteria was identified in the majority of patients — 70.6% (369/523). The presence of all five components (complete phenotype; 8.2%, 30/365), as well as a higher prevalence of fasting hyperglycaemia (53.7%, 196/365 vs. 38.6%, 49/127 in Asian women; p = 0.003) was observed predominantly in the Caucasian group. Conclusion. Significant ethnic differences in the prevalence and phenotypic structure of MS during the peri- and postmenopause were established, with the highest overall detection rate of the syndrome, its complete phenotype, and hyperglycaemia observed in Caucasian women. These findings support the need for developing ethnic-specific approaches to screening for metabolic disorders and preventing cardiometabolic diseases. Keywords: metabolic syndrome, perimenopause, postmenopause, ethnicity
- 30 December 2025
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 12_2025, 88-96
Association between extradiol and progesterone levels and chronic endometritis in women with reproductive disorders
- 30 December 2025
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 12_2025, 88-96
Association between extradiol and progesterone levels and chronic endometritis in women with reproductive disorders
- 17 December 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (5) , 52-59
Under what conditions is uterine myoma in women of reproductive age associated with the use of combined oral contraceptives?
Uterine myoma (UM) is a common benign tumor of smooth muscle cells of the myometrium, which is often associated with metabolic disorders. Hormonal contraceptives are used to control the duration and volume of menstrual bleeding in UM. At the same time, data on the relationship between the use of combined oral contraceptives (COCs) and uterine myoma are contradictory. The aim. To identify the relationship between uterine fibroids and the use of combined oral contraceptives in women of reproductive age, taking into account their ethnicity and the presence of metabolic disorders. Materials and methods. The results of a re-analysis of a cross-sectional study conducted earlier in Eastern Siberia (2016–2019) are presented. A total of 1347 women of reproductive age (34.33 ± 6.37 years) were included in the study, of which 198 participants had uterine fibroids. The study methods included a questionnaire survey, general clinical and gynecological examinations, pelvic ultrasound, and statistical analysis. Results. It was found that an increase in the likelihood of detecting uterine fibroids is associated with the use of COCs in the presence of metabolic syndrome and only in the Caucasian subpopulation (OR 3.287; 95% CI (1.490; 7.253)). The use of COCs is a factor associated with uterine fibroids in women with a BMI of more than 30 kg/m2, due to the subpopulation of Caucasian ethnicity, for whom the likelihood of having uterine fibroids is 6 times higher when using COCs than when not using COCs (OR 6.253, 95% CI (1.857; 21.054)). For Caucasians, the association between COC use and uterine fibroids was also demonstrated in patients with a BMI of less than 25 kg/m2 (OR 2.521; 95% CI (1.255; 5.064). Conclusion. In women of reproductive age, the association between uterine fibroids and the use of combined oral contraceptives is observed in women of Caucasian ethnicity. The presence of metabolic disorders is a key co-factor in the association between uterine fibroids and the use of hormonal contraceptives.
- 17 December 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (5) , 52-59
Under what conditions is uterine myoma in women of reproductive age associated with the use of combined oral contraceptives?
Uterine myoma (UM) is a common benign tumor of smooth muscle cells of the myometrium, which is often associated with metabolic disorders. Hormonal contraceptives are used to control the duration and volume of menstrual bleeding in UM. At the same time, data on the relationship between the use of combined oral contraceptives (COCs) and uterine myoma are contradictory. The aim. To identify the relationship between uterine fibroids and the use of combined oral contraceptives in women of reproductive age, taking into account their ethnicity and the presence of metabolic disorders. Materials and methods. The results of a re-analysis of a cross-sectional study conducted earlier in Eastern Siberia (2016–2019) are presented. A total of 1347 women of reproductive age (34.33 ± 6.37 years) were included in the study, of which 198 participants had uterine fibroids. The study methods included a questionnaire survey, general clinical and gynecological examinations, pelvic ultrasound, and statistical analysis. Results. It was found that an increase in the likelihood of detecting uterine fibroids is associated with the use of COCs in the presence of metabolic syndrome and only in the Caucasian subpopulation (OR 3.287; 95% CI (1.490; 7.253)). The use of COCs is a factor associated with uterine fibroids in women with a BMI of more than 30 kg/m2, due to the subpopulation of Caucasian ethnicity, for whom the likelihood of having uterine fibroids is 6 times higher when using COCs than when not using COCs (OR 6.253, 95% CI (1.857; 21.054)). For Caucasians, the association between COC use and uterine fibroids was also demonstrated in patients with a BMI of less than 25 kg/m2 (OR 2.521; 95% CI (1.255; 5.064). Conclusion. In women of reproductive age, the association between uterine fibroids and the use of combined oral contraceptives is observed in women of Caucasian ethnicity. The presence of metabolic disorders is a key co-factor in the association between uterine fibroids and the use of hormonal contraceptives.
- Open Access
- 19 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (22) , 2929
Personalized Low-Invasive Approach to Chronic Endometritis Evaluation in Premenopausal Women: Machine Learning-Based Modeling
Background/Objectives: Chronic endometritis (CE) is a well-known risk factor for recurrent implantation failure. However, the traditional approach to CE diagnosis has several drawbacks. On the other hand, there is a lot of evidence that some clinical, instrumental, and/or laboratory parameters of patients are associated with CE. The aim of this study is to build a CE prediction model using machine learning tools based on low-invasive pathological features. Methods: The data of 108 women (44 with and 64 without CE) from a multicenter perspective cross-sectional study was included in this study. Basic characteristics, reproductive history, laboratory and ultrasound indicators, and immunohistochemistry results were collected. Binary feature selection was performed using forward stepwise selection with logistic regression as the evaluation criterion. For each feature configuration, a gradient-boosting model was trained on decision trees with a binary logistic loss function. The models were evaluated and compared on test data using standard metrics. Results: We built five comparable predictive models for CE. The models yielded the following AUCs (95% CI): Model 1 (seven indicators)—0.704 (0.5170, 0.8907), Model 2 (seven indicators)—0.673 (0.4716, 0.8745), Model 3 (nine indicators)—0.677 (0.4916, 0.8622), Model 4 (five indicators)—0.758 (0.5913, 0.9241), and Model 5 (five indicators)—0.769 (0.5913, 0.9241). Models 2 and 5 have the better recall and precision values, but the differences were not significant. SHAP values indicated that serum adiponectin level (Model 2) and SHBG (Model 5) had the greatest association with CE risks. Conclusions: Models 2 and 5 show the most promising potential for clinical application, as they demonstrate superior recall and precision metrics and require assessment of only 5–7 risk markers (with only a few being non-routine) for their implementation.
- 19 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (22) , 2929
Open AccessPersonalized Low-Invasive Approach to Chronic Endometritis Evaluation in Premenopausal Women: Machine Learning-Based Modeling
Background/Objectives: Chronic endometritis (CE) is a well-known risk factor for recurrent implantation failure. However, the traditional approach to CE diagnosis has several drawbacks. On the other hand, there is a lot of evidence that some clinical, instrumental, and/or laboratory parameters of patients are associated with CE. The aim of this study is to build a CE prediction model using machine learning tools based on low-invasive pathological features. Methods: The data of 108 women (44 with and 64 without CE) from a multicenter perspective cross-sectional study was included in this study. Basic characteristics, reproductive history, laboratory and ultrasound indicators, and immunohistochemistry results were collected. Binary feature selection was performed using forward stepwise selection with logistic regression as the evaluation criterion. For each feature configuration, a gradient-boosting model was trained on decision trees with a binary logistic loss function. The models were evaluated and compared on test data using standard metrics. Results: We built five comparable predictive models for CE. The models yielded the following AUCs (95% CI): Model 1 (seven indicators)—0.704 (0.5170, 0.8907), Model 2 (seven indicators)—0.673 (0.4716, 0.8745), Model 3 (nine indicators)—0.677 (0.4916, 0.8622), Model 4 (five indicators)—0.758 (0.5913, 0.9241), and Model 5 (five indicators)—0.769 (0.5913, 0.9241). Models 2 and 5 have the better recall and precision values, but the differences were not significant. SHAP values indicated that serum adiponectin level (Model 2) and SHBG (Model 5) had the greatest association with CE risks. Conclusions: Models 2 and 5 show the most promising potential for clinical application, as they demonstrate superior recall and precision metrics and require assessment of only 5–7 risk markers (with only a few being non-routine) for their implementation.